Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

ZURA

Zura Bio Ltd

Jan 22 • 04:00PM ET

6.45

+0.13 2.06 %

Healthcare • Biotechnology • USA • NASD

Peers: AMGN REGN VRTX BIIB GILD INCY ALNY BMRN IONS NBIX

| Held by: VXF IWC SBIO AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	35.92%	Shs Outstand	65.02M	Perf Week	20.11%
Market Cap	419.40M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	0.00%	Shs Float	41.67M	Perf Month	51.05%
Enterprise Value	290.58M	PEG	-	EPS next Q	-0.20	Inst Own	69.81%	Short Float	6.84%	Perf Quarter	89.71%
Income	-62.52M	P/S	-	EPS this Y	-34.05%	Inst Trans	8.23%	Short Ratio	4.55	Perf Half Y	281.66%
Sales	0.00M	P/B	3.87	EPS next Y	-3.55%	ROA	-37.55%	Short Interest	2.85M	Perf YTD	23.09%
Book/sh	1.66	P/C	3.02	EPS next 5Y	-8.67%	ROE	-47.86%	52W High	6.41 0.62%	Perf Year	260.34%
Cash/sh	2.14	P/FCF	-	EPS past 3/5Y	- -	ROIC	-57.76%	52W Low	0.97 564.95%	Perf 3Y	-36.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	19.42% 12.83%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-19.69%	Oper. Margin	-	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.58	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	71.29	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.58	EPS Q/Q	19.34%	SMA20	25.02%	Beta	0.19	Target Price	16.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	45.45%	Rel Volume	2.57	Prev Close	6.32
Employees	30	LT Debt/Eq	0.00	Earnings	Nov 13 BMO	SMA200	152.15%	Avg Volume	625.69K	Price	6.45
IPO	Sep 03, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.78% -	Trades		Volume	1,611,076	Change	2.06%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-04-24	Initiated	Leerink Partners	Outperform	$15
Sep-05-24	Initiated	H.C. Wainwright	Neutral	$5
May-03-24	Initiated	Piper Sandler	Overweight	$26
Oct-10-23	Initiated	Ladenburg Thalmann	Buy	$10
Aug-25-23	Initiated	Oppenheimer	Outperform	$17
Jun-22-23	Initiated	Guggenheim	Buy	$20
Jun-14-23	Initiated	Chardan Capital Markets	Buy	$14
May-24-23	Initiated	Raymond James	Strong Buy	$20

Jan-21-26 08:50AM	Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer (Business Wire) +26.15%
Jan-12-26 06:30AM	Zura Bio Reports Business Updates and Outlook for 2026 (Business Wire)
Nov-29-25 01:26AM	Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress (Insider Monkey)
Nov-13-25 06:30AM	Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire) -9.72%
Aug-20-25 06:30AM	Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference (Business Wire)
08:15AM	Loading…
Aug-14-25 08:15AM	Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire) +8.18%
Jul-17-25 04:30PM	Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +51.94%
Jul-01-25 06:30AM	Zura Bio Announces Chief Financial Officer Transition (Business Wire)
May-27-25 06:30AM	Zura Bio to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-20-25 06:30AM	Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa (Business Wire)
May-08-25 06:30AM	Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire)
Mar-25-25 06:30AM	Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates (Business Wire) +10.37%
Feb-24-25 06:30AM	Zura Bio to Present at the Leerink Partners Global Healthcare Conference (Business Wire)
Dec-23-24 06:30AM	Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis (Business Wire)
Nov-25-24 06:30AM	Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference (Business Wire) +12.09%
04:30PM	Loading…
Nov-14-24 04:30PM	Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis (Business Wire) -17.81% -12.22%
Nov-07-24 06:30AM	Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates (Business Wire)
Oct-30-24 06:30AM	Zura Bio to Participate in Two Upcoming Investor Conferences in November (Business Wire)
Sep-03-24 06:00AM	Zura Bio to Present at Three Upcoming Investor Conferences in September (Business Wire)
Aug-13-24 09:21AM	Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights (Business Wire)
Aug-12-24 04:05PM	Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants (Business Wire)
Aug-09-24 04:05PM	Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants (Business Wire)
Aug-01-24 08:00AM	Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors (GlobeNewswire)
Jul-12-24 06:10AM	Zura Bio Commences Warrant Exchange Offer and Consent Solicitation (Business Wire) -6.08%
06:08AM	The 3 Most Undervalued Biotech Stocks to Buy in July 2024 (InvestorPlace)
Jun-14-24 06:00AM	Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024 (Business Wire)
Jun-06-24 06:00AM	Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology (Business Wire) -8.11%
Jun-03-24 06:00AM	Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024 (Business Wire) -7.05%
May-31-24 09:55AM	Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know (Zacks)
May-29-24 06:00AM	Zura Bio Announces Participation in June Investor Conferences (Business Wire)
06:18AM	Loading…
May-24-24 06:18AM	3 Penny Stocks to Buy Now: May 2024 (InvestorPlace)
May-15-24 09:55AM	How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84% (Zacks)
May-14-24 12:00PM	Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know (Zacks) +7.72%
May-12-24 03:26PM	13 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-10-24 03:14PM	Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments (GuruFocus.com)
May-09-24 01:56PM	ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024 (InvestorPlace)
06:00AM	Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights (Business Wire)
Apr-25-24 02:18AM	Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA) (GuruFocus.com) +9.37%
Apr-18-24 09:22AM	Zura Bio Announces Oversubscribed $112.5 Million Private Placement (Business Wire) +17.89%
Apr-08-24 06:00AM	Zura Bio Announces Robert Lisicki as CEO and Director (Business Wire)
Mar-28-24 11:54AM	ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023 (InvestorPlace) +10.78%
06:00AM	Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer (Business Wire)
Mar-04-24 06:00AM	Zura Bio Announces Participation at March Conferences (Business Wire)
Feb-02-24 06:00AM	Zura Bio Announces Participation at February Investor Conferences (Business Wire) +6.11%
Jan-08-24 06:00AM	Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO (Business Wire)
Jan-03-24 06:00AM	Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit (Business Wire)
Dec-04-23 06:00AM	Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok (Business Wire)
Nov-14-23 06:00AM	Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors (Business Wire) +10.00%
Nov-13-23 06:30AM	Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights (Business Wire) -6.54%
Sep-12-23 05:00AM	Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute (Business Wire)
Sep-05-23 08:55PM	Oppenheimer Says These 2 Stocks Could Double Your Money Heres Why They Could Jump (TipRanks)
Aug-25-23 09:42AM	Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls (The Fly)
Aug-14-23 07:00AM	Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights (Business Wire)
Jun-23-23 06:30AM	Zura Bio to Join the Russell 2000® and Russell 3000® Indexes (Business Wire) -5.69%
Jun-06-23 06:34AM	Daily Vickers Top Buyers & Sellers for 06/06/2023 (Argus Research) +16.80%
04:00AM	Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist (Business Wire)
Jun-01-23 10:20AM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks) +10.82%
Apr-27-23 07:39AM	Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases (Business Wire)
Apr-14-23 05:00AM	Zura Bio Announces Appointment of Chief Scientific Officer (Business Wire)
Mar-27-23 09:35AM	Zura Bio Limited Announces Share Redemptions and Lock-up Agreement (Business Wire) -42.76%
Mar-21-23 06:13AM	Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp (Business Wire) -11.27%

Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZURA

Zura Bio Ltd

Upgrade your FINVIZ experience